|
1
|
Vaglio A, Salvarani C and Buzio C:
Retroperitoneal fibrosis. Lancet. 367:241–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amis ES Jr: Retroperitoneal fibrosis. AJR
Am J Roentgenol. 157:321–329. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caiafa RO, Vinuesa AS, Izquierdo RS,
Brufau BP, Ayuso Colella JR and Molina CN: Retroperitoneal
fibrosis: Role of imaging in diagnosis and follow-up.
Radiographics. 33:535–552. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koep L and Zuidema GD: The clinical
significance of retroperitoneal fibrosis. Surgery. 81:250–257.
1977.PubMed/NCBI
|
|
5
|
Reiner I, Yachia D, Nissim F and
Fishelowitz Y: Retroperitoneal fibrosis in association with
urothelial tumor. J Urol. 132:115–116. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Murray SM and Woo-Ming MO: Retroperitoneal
‘fibrosis’ due to carcinoma of the ureter. Br J Urol. 38:424–427.
1966. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calvert AH, Newell DR, Gumbrell LA,
O'Reilly S, Burnell M, Boxall FE, Siddik ZH, Judson IR, Gore ME and
Wiltshaw E: Carboplatin dosage: Prospective evaluation of a simple
formula based on renal function. J Clin Oncol. 7:1748–1756. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stillwell TJ, Rife CC and Lieber MM:
Bladder carcinoma presenting with rectal obstruction. Urology.
34:238–240. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tokunaga K, Furuta A, Arizono S, Teramoto
Y, Negoro H, Kido A, Isoda H and Togashi K: Duodenal obstruction
induced by retroperitoneal progression of bladder cancer: A report
of two cases. Abdom Radiol (NY). 44:1223–1229. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iwamoto N, Oikawa M, Kukimoto T, Ito J,
Murakami K and Kaiho Y: Renal pelvis cancer with initial symptoms
of malignant gastric outlet obstruction. IJU Case Rep. 6:475–478.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Andersen K, Burroughs S, Munis A, Hoff RT
and Shapiro A: Gastric outlet obstruction as the initial
presentation of upper tract urothelial carcinoma. Case Rep
Gastrointest Med. 2020:88500622020.PubMed/NCBI
|
|
12
|
Brandt AS, Kamper L, Kukuk S, Haage P and
Roth S: Associated findings and complications of retroperitoneal
fibrosis in 204 patients: Results of a urological registry. J Urol.
185:526–531. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SJ, Eun JS, Kim MJ, Song YW and Kang
Y: Association of retroperitoneal fibrosis with malignancy and its
outcomes. Arthritis Res Ther. 23:2492021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brun B, Laursen K, Sørensen IN, Lorentzen
JE and Kristensen JK: CT in retroperitoneal fibrosis. AJR Am J
Roentgenol. 137:535–538. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fagan CJ, Larrieu AJ and Amparo EG:
Retroperitoneal fibrosis: Ultrasound and CT features. AJR Am J
Roentgenol. 133:239–243. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yeung KT and Yang J:
Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol.
11:28–39. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brandt AS, Dreger NM, Müller E, Kukuk S
and Roth S: New (and old) aspects of retroperitoneal fibrosis.
Urologe A. 56:887–894. 2017.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Łoń I, Wieliczko M, Lewandowski J and
Małyszko J: Retroperitoneal fibrosis is still an underdiagnosed
entity with poor prognosis. Kidney Blood Press Res. 47:151–162.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cronin CG, Lohan DG, Blake MA, Roche C,
McCarthy P and Murphy JM: Retroperitoneal fibrosis: A review of
clinical features and imaging findings. AJR Am J Roentgenol.
191:423–431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alfred Witjes J, Max Bruins H, Carrión A,
Cathomas R, Compérat E, Efstathiou JA, Fietkau R, Gakis G, Lorch A,
Martini A, et al: European association of urology guidelines on
muscle-invasive and metastatic bladder cancer: Summary of the 2023
guidelines. Eur Urol. 85:17–31. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rouprêt M, Seisen T, Birtle AJ, Capoun O,
Compérat EM, Dominguez-Escrig JL, Gürses Andersson I, Liedberg F,
Mariappan P, Hugh Mostafid A, et al: European association of
urology guidelines on upper urinary tract urothelial carcinoma:
2023 Update. Eur Urol. 84:49–64. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cathomas R, Lorch A, Bruins HM, Compérat
EM, Cowan NC, Efstathiou JA, Fietkau R, Gakis G, Hernández V,
Espinós EL, et al: The 2021 updated European association of urology
guidelines on metastatic urothelial carcinoma. Eur Urol. 81:95–103.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Geynisman DM, Broughton E, Hao Y, Zhang Y,
Le T and Huo S: Real-world treatment patterns and clinical outcomes
among patients with advanced urothelial carcinoma in the United
States. Urol Oncol. 40:195.e1–195.e11. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dogliotti L, Cartenì G, Siena S, Bertetto
O, Martoni A, Bono A, Amadori D, Onat H and Marini L: Gemcitabine
plus cisplatin versus gemcitabine plus carboplatin as first-line
chemotherapy in advanced transitional cell carcinoma of the
urothelium: Results of a Randomized phase 2 trial. Eur Urol.
52:134–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
